
AI for Medtech/Healthcare and other FDA-regulated products - Invent Penn State Venture & IP Conference
Tina Hu-Rogers, shareholder and Life Sciences Industry Group Co-Leader, will serve as a panelist during the “AI for Medtech/Healthcare and other FDA-regulated products” at the Penn State Venture & IP Conference. Adam Wicks, shareholder and Private Equity and Venture Capital Practice Group Leader, will moderate the panel. The other panelists will include Brad Holden, CEO of Resilient Lifescience; and Jenn Kulp, Associate Director, Legal Services of Prelude Therapeutics.
Professionals
Related Services & Industries